Survival curves obtained by the KM Plotter platform show that increased expression of AFAP1 transcripts is associated with short disease-free interval in patients with Luminal B (p = 0.0057), HER2 + (p = 0.017), and basal (p = 0.0052) tumors and worse overall survival Luminal A (0.02) and HER2 + (p <0.0001) tumor subtypes. This evidence concerns the gene AFAP1 and neoplasm.